Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

The discovery, published in the journal Cell, has sparked global interest due to its similarities to SARS-CoV-2, the virus ...

When the SARS-CoV-2 virus enters the human body, it breaks into cells with the help of two proteins that it finds there, ACE2 and TMPRSS2. While there has been much discussion of viral infection in ...

The new virus, emerging in Wuhan, China, is called SARS-CoV-2 and is responsible for the disease known as COVID-19. SARS-CoV-2 spread quickly around the globe. Unlike SARS-CoV or MERS-CoV, SARS-CoV-2 ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

“I thought, ‘What can I do for the next 20 or 30 years?’” He found an answer in SARS-CoV-2, the virus responsible for the COVID-19 pandemic, that was rapidly spreading around the worl ...

For all the mysteries that remain about the novel coronavirus and the COVID-19 disease it causes, scientists have generated an incredible amount of fine-grained knowledge in a surprisingly short time.

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...